Mesenteric lymph flow in endotoxemic guinea pigs

Lymphatic Research and Biology

Volumn 9, Issue 3, 2011, Pages 129-134

  Nemoto, Kayo ^a,b   Sato, Hitoshi ^a   Tanuma, Kumiko ^a   Okamura, Tadao ^a  

^a Shinjuku Vocational College of Acupuncture and Judo Therapy   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EVANS BLUE; POLYETHYLENE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; ENDOTOXEMIA; EXPERIMENTAL GUINEA PIG; FLOW RATE; JUGULAR VEIN; LYMPH FLOW; MALE; MESENTERIC LYMPH FLOW; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANIMALS; BLOOD PRESSURE; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; EVANS BLUE; GUINEA PIGS; LIPOPOLYSACCHARIDES; LYMPH; LYMPHATIC VESSELS; MALE; MESENTERY;

EID: 80955143789     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2011.0006     Document Type: Article

References (20)

1. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115:457.
2. Ninomiya N, Nemoto K, Kaji M, Shimada Y, Yamamoto Y. Regulation of the endocannabinoid system in endotoxicosis of conscious guinea pigs. J Jap Assoc Acute Med 2005;16: 218-226.
3. Shiga N, Nemoto K, Shimada Y, Nakanowatari Y, Ninomiya N, Yamamoto Y. Elimination of 2-arachidonoylglycerol action by direct hemoperfusion through fibers immobilizing polymyxin B: An experimental study in conscious guinea pigs. Therap Apheresis Dialysis 2006;10:504-509. (Pubitemid 44952938)
4. Irie K, Fujii E, Ishida H, Wada K, Suganuma T, Nishikori T, Yoshioka T, Muraki T. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin. Brit J Phramacol 2001;133:237-242. (Pubitemid 32507042)
5. Fukumoto T, Matsukawa A, Yoshimura T, Edamitsu S, Ohkawara S, Takagi K, Yoshinaga M. IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy. J Leukoc Biol 1998;63: 584-590. (Pubitemid 28193771)
6. Semaeva E, Tenstad O, Skavland J, Enger M, Iversen PO, Gjertsen BT, Wiig H. Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation. J Immunol 2010;184:4547-4556.
7. Yoffey JM, Coutice FC. Flow and composition of lymph. In Lymphatics, Lymph and the Lymphomyeloid Complex, Academic Press: London-New York, 1970, pp.160-205.
8. Udaka K, Takeuchi Y, Movat HZ. Simple method for quantification of enhanced vascular permeability. Proc Soc Exp Biol Med 1970;133:1384.
9. Rothschild MA, Bauman A, Yalow RS, Berson SA. Tissue distribution of I131 labeled serum albumin following intravenous administration. J Clin Invest 1955;34:1354-1358.
10. Green TP, Johnson DE, Marchessault RP, Gatto CW. Transvascular efflux and tissue accrual of Evans blue: Effects of endotoxin and histamine. J Lab Clin Med 1988;111:173-183. (Pubitemid 18074320)
11. Galanos C, Freudenberg MA, Reutter W. Galactosamineinduced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939-5943. (Pubitemid 10216692)
12. Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley- Topliffe L, Tesini B, Liang X, Valentine C, Hellman J, Hayden D, Cavaillon JM. Resilience to bacterial infection:Difference between species could be due to proteins in serum. J Infect Dis 2010;201:223-232.
13. West KL, Fernandez ML. Guinea pig as models to study the hypocholesterolemic effecs of drugs. Cardiovasc Drug Rev 2004;22:55-70. (Pubitemid 38379634)
14. Lin LW, Chen HY, Wu CR, Liao PM, Lin YT, Hsieh MT, Ching H. Comparison with various parts of Broussonetia papyrifera as to the antinociceptive and anti- inflammatory activities in rodents. Biosci Biotechnol Biochem 2008;72: 2377-2384.
15. Ohhashi T, Azuma T, Sakaguchi M. Active and passive mechanical characteristics of bovine mesenteric lymphatics. Am J Physiol 1980;239:H88-H95.
16. Kuroshima S, Sawa Y, Kawamoto T, Yamaoka Y, Notani K, Yoshida S, Inoue N. Expression of Toll-like receptors 2 and 4 on human intestinal lymphatic vessels. Microvasc Res 2004; 67:90-95. (Pubitemid 38050227)
17. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86:279-368.
18. Ninomiya N, Nemoto K, Okamura T, Yamamoto Y. A novelexperimental method for the study of intestinal aralysis due to endotoxicosis. J Jap Assoc Acute Med 2003;14:241-250.
19. Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994;271:1836-1843.
20. Abraham E, Auzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S. Double-blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock. Lancet 1998;351:929-933. (Pubitemid 28138465)